Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

Regeneron Pharma(REGN.US)

Event Tracking

Mar24

REGN's Dupixent® Gets Approval in Japan for Bullous Pemphigoid

06:01

Feb27

Regeneron and Sanofi's Dupixent Gets Positive Opinions from EMA

12:00

Feb19

Regeneron Announces FDA Acceptance of Biological License Application for FOP Treatment Garetosmab

12:02

Feb17

Ocular Therapeutix's Eye Drug Axpaxli Surpasses Regeneron's Eylea

12:00

Feb4

Regeneron Pharmaceuticals Releases Q4 2025 Earnings Call Transcript

18:33

Regeneron Pharmaceuticals Reports Q4 2025 Net Product Sales of Dupixent and Kevzara at $18.38 Billion

14:10

Schedules & Filings

Schedules

Filings

Apr29

Earning Release(EST)

FY2026 Q1 Earning Release

Mar5

Distribution Plan(EST)

Cash dividend 0.94 USD

Feb20

Distribution Plan(EST)

Cash dividend 0.94 USD

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

Regeneron Pharma(REGN.US)

Regeneron Pharma Stock Performance Chart

Trending